Regeneron Pharmaceuticals Inc (REGN)

Operating profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	3,990,700	3,973,400	3,904,900	3,851,800	4,047,100	4,221,000	4,333,700	4,427,100	4,738,900	6,231,800	6,855,300	9,092,600	8,946,800	7,474,100	6,680,000	3,989,200	3,576,600	3,085,300	2,770,700	2,429,900
Revenue (ttm)	US$ in thousands	14,185,900	13,812,700	13,436,900	13,029,000	13,044,200	13,025,200	12,601,200	12,306,100	12,113,500	13,654,100	14,171,800	16,451,800	16,014,400	13,499,700	12,328,800	9,147,000	8,455,000	8,201,600	7,974,500	7,957,900
Operating profit margin		28.13%	28.77%	29.06%	29.56%	31.03%	32.41%	34.39%	35.97%	39.12%	45.64%	48.37%	55.27%	55.87%	55.36%	54.18%	43.61%	42.30%	37.62%	34.74%	30.53%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $3,990,700K ÷ $14,185,900K
= 28.13%

Regeneron Pharmaceuticals Inc's operating profit margin has shown fluctuation over the years, starting at 30.53% on March 31, 2020, and reaching a peak of 55.87% on December 31, 2021. However, there has been a gradual decline since then, with the operating profit margin decreasing to 28.13% by the end of December 31, 2024.

The company experienced significant improvements in its operating profit margin from 2020 to 2021, indicating enhanced operational efficiency and cost management during that period. The peak in December 2021 suggests successful revenue growth and effective control over operating expenses.

However, the subsequent decline in the operating profit margin from June 2022 to December 2024 may be a cause for concern. It could indicate challenges in maintaining profitability, potentially due to increased operating expenses, pricing pressures, or other factors impacting the company's profitability.

Overall, monitoring Regeneron Pharmaceuticals Inc's operating profit margin trends is crucial for assessing its operational performance and financial health, as it reflects the company's ability to generate profits from its core business activities.